NMPA Approval

Olmesartan Medoxomil and Hydrochlorothiazide Tablets

Approval Number

国药准字H20243284

Company珠海润都制药股份有限公司

Registration Date

February 23, 2024

Drug Information

Generic Name

奥美沙坦酯氢氯噻嗪片

Dosage Form

片剂

Strength

每片含奥美沙坦酯40mg与氢氯噻嗪25mg

Drug Type

化学药品

Registration Date

February 23, 2024

Company Information

Applicant Company

Company Name珠海润都制药股份有限公司

Company Address

珠海市金湾区三灶镇机场北路6号

Manufacturing Company

Company Name珠海润都制药股份有限公司

Company Address

珠海市金湾区三灶镇机场北路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯氢氯噻嗪片 - NMPA 批准文号 | MedPath